Details of the Drug

General Information of Drug (ID: DMZED0G)

Drug Name

AR-501

Synonyms

Gallium citrate; 27905-02-8; UNII-HT6C49L0ZP; Citric acid, gallium(II) salt; HT6C49L0ZP; CITRIC ACID, GALLIUM SALT (1:1); gallium;2-hydroxypropane-1,2,3-tricarboxylate; 30403-03-3; EINECS 248-721-1; NSC 15011; gallium 2-hydroxypropane-1,2,3-tricarboxylate; SCHEMBL37799; DTXSID50952742; 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, gallium salt

Indication

Disease Entry	ICD 11	Status	REF
Cystic fibrosis	CA25	Phase 1/2	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL is unavailable

2D MOL

Chemical Identifiers

Formula: C6H5GaO7
Canonical SMILES: C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Ga+3]
InChI: 1S/C6H8O7.Ga/c7-3(8)1-6(13,5(11)12)2-4(9)10;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);/q;+3/p-3
InChIKey: YEEGWNXDUZONAA-UHFFFAOYSA-K

Cross-matching ID

PubChem CID: 34058
CAS Number: 27905-02-8
UNII: HT6C49L0ZP
DrugBank ID: DB17893
TTD ID: D1MK7G

References

1	ClinicalTrials.gov (NCT03669614) SAD and MAD of Inhaled AR-501 in Health Adults and P. Aeruginosa Infected Cystic Fibrosis Subjects. U.S. National Institutes of Health.